Professor | Shengying Qin | Asia Growth Partners

Name	Shengying Qin
Contact Information	chinsir@163.com
Language ability	Chinese, English
Province	Shanghai

Name

Shengying Qin

Contact Information

chinsir@163.com

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Shanghai Jiao Tong University
Faculty	Life Sciences
Academic Background & Achievements	2005 - PhD from Shanghai Jiao Tong University 2014-2015 - Visiting Scholar at Harvard University and Broad Institute Published over 100 academic papers, applied for 33 patents, 12 granted, 3 transferred Edited and co-authored 6 books, developed 4 guidelines and standards
Work Experience	Current - Director of the Personalized Medicine Research Center at Shanghai Jiao Tong University Bio-X Institutes Current - Director of the Cross-disciplinary Talent Training Base in Personalized Medicine at Shanghai Jiao Tong University
Awards	International Human Genetics Society Young Researcher Award Second Prize in the National University Biology Micro-course Competition Shanghai Jiao Tong University Morning Star Scholar SMC Excellent Young Teacher Award First Prize in the Excellent Postdoctoral Award Fund

University/Lab Affiliation and Title

Shanghai Jiao Tong University

Faculty

Life Sciences

Academic Background & Achievements

2005 - PhD from Shanghai Jiao Tong University
2014-2015 - Visiting Scholar at Harvard University and Broad Institute
Published over 100 academic papers, applied for 33 patents, 12 granted, 3 transferred
Edited and co-authored 6 books, developed 4 guidelines and standards

Work Experience

Current - Director of the Personalized Medicine Research Center at Shanghai Jiao Tong University Bio-X Institutes
Current - Director of the Cross-disciplinary Talent Training Base in Personalized Medicine at Shanghai Jiao Tong University

Awards

International Human Genetics Society Young Researcher Award
Second Prize in the National University Biology Micro-course Competition
Shanghai Jiao Tong University Morning Star Scholar SMC Excellent Young Teacher Award
First Prize in the Excellent Postdoctoral Award Fund

Areas of Focus	Pharmacogenomics and Personalized Medicine Birth Defects and Disease Genomics
Publications	Improving polygenic prediction in ancestrally diverse populations, Shengying Qin et al., 2022 Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes, Shengying Qin et al., 2022 MiR143-3p-mediated neuregulin-1-dependent mitochondrial dysfunction contributes to olanzapine resistance in refractory schizophrenia, Shengying Qin et al., 2022 Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese, Shengying Qin et al., 2021 Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis, Shengying Qin et al., 2020 A host-based whole genome sequencing study reveals novel risk loci associated with severity of influenza A(H1N1)pdm09 infection, Shengying Qin et al., 2020 FKBP51 promotes invasion and migration by increasing the autophagic degradation of TIMP3 in clear cell renal cell carcinoma, Shengying Qin et al., 2021 Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia?, Shengying Qin et al., 2020 Genome-Wide Analysis of DNA Methylation and Antituberculosis Drug-Induced Liver Injury in the Han Chinese Population, Shengying Qin et al., 2019 Comparative genetic architectures of schizophrenia in East Asian and European populations, Shengying Qin et al., 2019

Areas of Focus

Pharmacogenomics and Personalized Medicine
Birth Defects and Disease Genomics

Publications

Improving polygenic prediction in ancestrally diverse populations, Shengying Qin et al., 2022
Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes, Shengying Qin et al., 2022
MiR143-3p-mediated neuregulin-1-dependent mitochondrial dysfunction contributes to olanzapine resistance in refractory schizophrenia, Shengying Qin et al., 2022
Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese, Shengying Qin et al., 2021
Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis, Shengying Qin et al., 2020
A host-based whole genome sequencing study reveals novel risk loci associated with severity of influenza A(H1N1)pdm09 infection, Shengying Qin et al., 2020
FKBP51 promotes invasion and migration by increasing the autophagic degradation of TIMP3 in clear cell renal cell carcinoma, Shengying Qin et al., 2021
Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia?, Shengying Qin et al., 2020
Genome-Wide Analysis of DNA Methylation and Antituberculosis Drug-Induced Liver Injury in the Han Chinese Population, Shengying Qin et al., 2019
Comparative genetic architectures of schizophrenia in East Asian and European populations, Shengying Qin et al., 2019

Pharmacogenomics Personalized Medicine Birth Defects Disease Genomics Molecular Markers Drug Reactions High-Throughput Technologies Disease Treatment Precision Medicine Molecular Mechanisms

Shengying Qin - Shanghai Jiao Tong University

Lu Daru - Fudan University

Zhi John Lu - Tsinghua University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us